Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its fourth quarter/year-end 2012 financial results conference call for 8:30 a.m. ET on Thursday, February 14, 2013. The schedules for the press release and conference call are as follows:
|-- Q4 & YE 2012 Press Release:||February 14, 2013 at 7:00 a.m. ET|
|-- Q4 & YE 2012 Conference Call:||February 14, 2013 at 8:30 a.m. ET|
|-- Domestic Dial In Number:||877-407-8037|
|-- International Dial In Number:||201-689-8037|
|-- Conference ID #||407848|
If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 407848.
The conference call will also be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts.
About IncyteIncyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary small molecule drugs for oncology and inflammation. For additional information on Incyte, please visit the Company's web site at www.incyte.com.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV